INCREASED BONE-FORMATION BY INTERMITTENT PARATHYROID-HORMONE ADMINISTRATION IS DUE TO THE STIMULATION OF PROLIFERATION AND DIFFERENTIATION OF OSTEOPROGENITOR CELLS IN BONE-MARROW
S. Nishida et al., INCREASED BONE-FORMATION BY INTERMITTENT PARATHYROID-HORMONE ADMINISTRATION IS DUE TO THE STIMULATION OF PROLIFERATION AND DIFFERENTIATION OF OSTEOPROGENITOR CELLS IN BONE-MARROW, Bone, 15(6), 1994, pp. 717-723
In order to examine the mechanism of the anabolic effect of parathyroi
d hormone (PTH) on bone formation, human PTH(1-34) [hPTH(1-34)] (30 mu
g/kg) was injected subcutaneously to 9-week-old rats 5 times a week f
or 1 or 3 weeks. Trabecular bone volume (BV/TV) in the tibial metaphys
is was not significantly different between the PTH- and vehicle-treate
d groups, but the parameters related to bone formation, including oste
oid surface (OS/BS), mineralizing surface (MS/BS), mineral apposition
rate (MAR), and bone formation rate (BFR/BS), were significantly incre
ased as early as 1 week after PTH treatment. And the parameters relate
d to bone resorption including eroded surface (ES/BS) and osteoclast n
umber (N.Oc/BS) were also significantly increased as early as 1 week a
fter PTH treatment. Treatment with PTH for 1 week induced no significa
nt increase in bone mineral density at the femoral metaphysis, whereas
the same treatment for 3 weeks induced a significant increase. When b
one marrow cells isolated from femora and tibiae of either PTH-or vehi
cle-treated rats were cultured at a high density (2 x 10(7) cells/one
well of 24-multiwell plate), cellular alkaline phosphatase (ALP) activ
ity was significantly increased in the cells isolated from PTH-treated
rats compared with vehicle-treated rats. When bone marrow cells were
cultured at a low density (4 x 10(6) cells/a one well of 6-multiwell p
late) to generate colonies (colony forming unit-fibroblastic, CFU-F),
PTH induced apparent increases in both the total number of CFU-F and t
he number of ALP-positive CFU-F. The ratio of the latter to the former
was significantly higher in the PTH-treated group than in the vehicle
-treated group. These findings suggest that the anabolic effect of PTH
is, at least in part, due to the stimulation of proliferation and dif
ferentiation of osteoprogenitor cells in bone marrow.